Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

PEA reduces pain by increasing neurosteroid synthesis in the spinal cord.

A new compound shows promise as a topical treatment for hair loss.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Tamsulosin can worsen sleep apnea in some patients.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Drug repurposing can be cost-effective but needs more testing for safety and effectiveness.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Pantotherapy is more effective for treating androgenetic alopecia than darsonvalization.

The nutritional supplement Pilopeptan® WOMAN improved hair growth and thickness in women with hair loss.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

A new treatment plan for hair loss combines targeted therapies and regenerative strategies to stabilize, reverse, and maintain hair growth.

BroadAMP-GPT effectively creates antimicrobial peptides to fight drug-resistant bacteria.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.